CVX Research Update — June 20, 2026
Updated Thesis
Chevron Corporation is a leading integrated oil and gas company with a strong competitive moat based on its scale, advantaged upstream resource positions, and integrated infrastructure. The company benefits from a stable and experienced leadership team, with CEO Mike Wirth having over 40 years at Chevron and a conservative capital allocation approach focused on dividends and opportunistic buybacks. Despite these strengths, Chevron is currently overvalued, trading approximately 3% above its fair value estimate of $167.85, with a P/E trailing and forward multiple of 29.99 and an EV/EBITDA of 9.3.
The investment grade as of this refresh is D — solid business quality. Medium-tier business, overvalued with 3.3% downside to $167.85 fair value
Key Metrics at a Glance
- Revenue growth: +3.2% year over year
- Net margin: 5.9%
- Forward P/E: 30.0x
- Fair value upside: -3.3% to our estimate of $168
Current price: $173.63
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Chevron Corporation remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full CVX research →](/stocks/CVX)